Keyphrases
30-day Mortality
16%
Asian Population
16%
Bleeding
16%
Bleeding Site
16%
Coagulation
33%
Coagulopathy
16%
Disability
16%
Dose-finding Trial
16%
Dynamic Process
16%
Early Neurological Deterioration
16%
Europe
16%
Health Problems
16%
Hematoma Growth
83%
Hematoma Volume
16%
Hemophilia
16%
Hemostasis
33%
Hemostatic Therapy
100%
High Morbidity
33%
High Mortality
16%
Hyperacute
16%
Intracerebral Hemorrhage
100%
Natural History
100%
NovoSeven
16%
Placebo-controlled
16%
Randomized Double-blind
16%
Recombinant Activated Factor VII (rFVIIa)
50%
Spontaneous Intracerebral Hemorrhage
16%
Ultra-early
100%
Medicine and Dentistry
Apoplexy
42%
Bleeding
28%
Blood Stasis
28%
Cerebral Hemorrhage
100%
Coagulopathy
14%
Deterioration
14%
Diseases
14%
Factor VII
14%
Hematoma
85%
Hemostat
100%
Patient with Hemophilia
14%
Placebo
14%
Prospective Study
14%
Recombinant Blood Clotting Factor 7a
14%
Retrospective Study
14%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
28%
Blood Clotting Disorder
14%
Blood Clotting Factor 7
14%
Blood Stasis
28%
Brain Hemorrhage
100%
Cerebrovascular Accident
42%
Deterioration
14%
Diseases
14%
Haemophilia A
14%
Hematoma
85%
Hemostatic Agent
100%
Placebo
14%
Prospective Study
14%
Recombinant Blood Clotting Factor 7a
14%
Retrospective Study
14%